The human proteomic revolution proceeds with high-throughput assessment, AI analytics, correlation with health and disease, drug interactions, biomarkers cell.com/cell/fulltext/…

Live from #ASH2024 very excited to present two of my stories and connect with friends! #CHIP #AML #Germlinepredisposition

A bloody awesome welcome at #ASH2024 this morning! #proudhematologist

Learning from the amazing Jyoti Nangalia on an approach that has revolutionised the way we study hematopoiesis! Happening now #ASH2024

I am deeply honored to be featured as the December member by NANS Official! NANS has been my professional home since my residency days, offering an inspiring community of clinicians and scientists passionate about advancing neuromodulation. As both a neurosurgeon and researcher, I

One more postdoctoral position is available in my lab at Houston Methodist, focusing on neurorestoration and neural interfaces for the brain, spinal cord, and peripheral nerves. If interested, please contact me directly or visit the link below: careers-houstonmethodist.icims.com/jobs/63311/pos… Please

Just out: World’s Best Hospitals rankings. Newsweek newsweek.com/rankings/world… #1 Mayo Clinic

I had the chance to speak with Melissa Wilson on FOX26Houston for #PurpleDay about epilepsy—its signs, symptoms, and treatments. Grateful to help raise awareness on this important topic. Watch the interview here: 🎥 iqmediacorp.com/ClipPlayer/?Cl… #Epilepsy #EpilepsyAwareness

Promising lab research led by Profs Huntly & Vassiliou Cambridge Stem Cell Institute shows diabetes drug could prevent a type of aggressive blood cancer. Next step is clinical trials in people at risk. Funded by Blood Cancer UK Science and Innovation at Cancer Research UK The Leukemia & Lymphoma Society Wellcome ➡️ crukcambridgecentre.org.uk/news/lab-resea…

ASH is committing more than $12 million to address research funding challenges and support the next generation of hematologists. Learn more: ow.ly/sK3050W735W #Fight4Hematology

Thrilled to begin a new chapter at BCM! Alongside developing a CHIP clinic, I will continue research on how CH becomes MDS/AML, and how to stop it! 🙌🏻 Grateful to join the Texas Medical Center community and work with truly inspiring women in science Peggy Goodell and Katherine King MDPhD

With the disappointing announcement today by AbbVie of the negative result of the VERONA venetoclax/azacitidine trial, that brings the tally to (by my count) 17 consecutive negative randomized drug trials in higher-risk #MDSsm. This is a slide I made summarizing them./1

TP53-mutated acute myeloid leukemia and myelodysplastic syndrome are now well established as their own unique diagnostic entity, characterized by an exceptionally poor prognosis and inadequate therapeutic options. ow.ly/XMBu50WagUw #BloodSpotlight #myeloidneoplasia

🚨 New paper in Nature Genetics ! How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-related myeloid neoplasms? We uncovered this process through single-colony WGS! See the full paper here! nature.com/articles/s4158…

ENHANCE-2 study in P53+ AML 2 randomizations: Magro_AZA vs Ven_AZA Magro_AZA vs 7+3 ⭐️ magro_AZA did not improve OS ⭐️ magro_AZA did not have higher ORR ⭐️⭐️ OS was really low in all arms We need novel drugs for p53 mutated MN ashpublications.org/blood/article/…

Breaking news! The Erasmus Hematology Lectures start again on September 1 with Marc Dawson. As Marc presents from Australia this lecture will be at 1pm CEST! All other lecture will be at 4PM CEST! Check out the complete list of speakers for 2025! Enjoy and share the news!

I am incredibly excited to see Athernal Bio launch to tackle high-risk clonal hematopoiesis and blood cancer prevention, an area close to my heart and central to my work. Big things are coming and this is just the beginning! #CHIP #Cancerprevention linkedin.com/posts/athernal…

As I mark my first year at Houston Methodist, I’ve been reflecting on how far we’ve come in transforming our peripheral nerve and functional neurosurgery service. In just one year, we’ve evolved from a general functional neurosurgery practice into a truly ultra-specialized center